Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis. (Q51359685)
Jump to navigation
Jump to search
scientific article published on 27 October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis. |
scientific article published on 27 October 2016 |
Statements
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis. (English)
1 reference
1 reference
Kaj Blennow
1 reference
Henrik Zetterberg
1 reference
Markus Axelsson
1 reference
Fredrik Piehl
1 reference
Tomas Olsson
1 reference
Jan Lycke
1 reference
27 October 2016
1 reference
141
1 reference
2
1 reference
296-304
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference